Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169


Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.

Guenaga J, Garces F, de Val N, Stanfield RL, Dubrovskaya V, Higgins B, Carrette B, Ward AB, Wilson IA, Wyatt RT.

Immunity. 2017 May 16;46(5):792-803.e3. doi: 10.1016/j.immuni.2017.04.014.


Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.

Delpeut S, Sisson G, Black KM, Richardson CD.

J Virol. 2017 Apr 28;91(10). pii: e02191-16. doi: 10.1128/JVI.02191-16. Print 2017 May 15.


SARS-CoV fusion peptides induce membrane surface ordering and curvature.

Basso LG, Vicente EF, Crusca E Jr, Cilli EM, Costa-Filho AJ.

Sci Rep. 2016 Nov 28;6:37131. doi: 10.1038/srep37131.


Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240.

Gohain N, Tolbert WD, Orlandi C, Richard J, Ding S, Chen X, Bonsor DA, Sundberg EJ, Lu W, Ray K, Finzi A, Lewis GK, Pazgier M.

Sci Rep. 2016 Nov 9;6:36685. doi: 10.1038/srep36685.


A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Xiong S, Borrego P, Ding X, Zhu Y, Martins A, Chong H, Taveira N, He Y.

J Virol. 2016 Dec 16;91(1). pii: e01839-16. Print 2017 Jan 1.


HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.

Eggink D, de Taeye SW, Bontjer I, Klasse PJ, Langedijk JP, Berkhout B, Sanders RW.

J Virol. 2016 Nov 14;90(23):10587-10599. Print 2016 Dec 1.


Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.

Joyce MG, Zhang B, Ou L, Chen M, Chuang GY, Druz A, Kong WP, Lai YT, Rundlet EJ, Tsybovsky Y, Yang Y, Georgiev IS, Guttman M, Lees CR, Pancera M, Sastry M, Soto C, Stewart-Jones GB, Thomas PV, Van Galen JG, Baxa U, Lee KK, Mascola JR, Graham BS, Kwong PD.

Nat Struct Mol Biol. 2016 Sep;23(9):811-20. doi: 10.1038/nsmb.3267. Epub 2016 Aug 1.


Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.

Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, Druz A, Georgiev IS, Gorman J, Huang J, Joyce MG, Louder MK, Ma X, McKee K, O'Dell S, Pancera M, Yang Y, Blanchard SC, Mothes W, Burton DR, Koff WC, Connors M, Ward AB, Kwong PD, Mascola JR.

Science. 2016 May 13;352(6287):828-33. doi: 10.1126/science.aae0474.


A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance.

Watterson D, Robinson J, Chappell KJ, Butler MS, Edwards DJ, Fry SR, Bermingham IM, Cooper MA, Young PR.

Sci Rep. 2016 Mar 15;6:22791. doi: 10.1038/srep22791.


Dual Mutation Events in the Haemagglutinin-Esterase and Fusion Protein from an Infectious Salmon Anaemia Virus HPR0 Genotype Promote Viral Fusion and Activation by an Ubiquitous Host Protease.

Fourrier M, Lester K, Markussen T, Falk K, Secombes CJ, McBeath A, Collet B.

PLoS One. 2015 Oct 30;10(10):e0142020. doi: 10.1371/journal.pone.0142020. eCollection 2015.


The requirement of environmental acidification for Ibaraki virus infection to host cells.

Tsuruta Y, Shibutani ST, Watanabe R, Iwata H.

J Vet Med Sci. 2016 Jan;78(1):153-6. doi: 10.1292/jvms.15-0222. Epub 2015 Aug 28.


Mutations in the DI-DII Linker of Human Parainfluenza Virus Type 3 Fusion Protein Result in Diminished Fusion Activity.

Xie W, Wen H, Chu F, Yan S, Lin B, Xie W, Liu Y, Ren G, Zhao L, Song Y, Sun C, Wang Z.

PLoS One. 2015 Aug 25;10(8):e0136474. doi: 10.1371/journal.pone.0136474. eCollection 2015.


Broad-spectrum antiviral agents.

Zhu JD, Meng W, Wang XJ, Wang HC.

Front Microbiol. 2015 May 22;6:517. doi: 10.3389/fmicb.2015.00517. eCollection 2015. Review.


Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present.

Vaughan K, Ponomarenko J, Peters B, Sette A.

PLoS One. 2015 May 22;10(5):e0127108. doi: 10.1371/journal.pone.0127108. eCollection 2015. Review.


Discovery of imidazopyridine derivatives as highly potent respiratory syncytial virus fusion inhibitors.

Feng S, Hong D, Wang B, Zheng X, Miao K, Wang L, Yun H, Gao L, Zhao S, Shen HC.

ACS Med Chem Lett. 2015 Jan 25;6(3):359-62. doi: 10.1021/acsmedchemlett.5b00008. eCollection 2015 Mar 12.


Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket.

Su Y, Chong H, Qiu Z, Xiong S, He Y.

J Virol. 2015 Jun;89(11):5801-11. doi: 10.1128/JVI.00373-15. Epub 2015 Mar 18.


Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.

Georgiev IS, Joyce MG, Yang Y, Sastry M, Zhang B, Baxa U, Chen RE, Druz A, Lees CR, Narpala S, Schön A, Van Galen J, Chuang GY, Gorman J, Harned A, Pancera M, Stewart-Jones GB, Cheng C, Freire E, McDermott AB, Mascola JR, Kwong PD.

J Virol. 2015 May;89(10):5318-29. doi: 10.1128/JVI.03451-14. Epub 2015 Mar 4.


Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formation.

Zhang Y, Bartz R, Grigoryan G, Bryant M, Aaronson J, Beck S, Innocent N, Klein L, Procopio W, Tucker T, Jadhav V, Tellers DM, DeGrado WF.

ACS Chem Biol. 2015 Apr 17;10(4):1082-93. doi: 10.1021/cb500759p. Epub 2015 Jan 28.


Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

Pancera M, Zhou T, Druz A, Georgiev IS, Soto C, Gorman J, Huang J, Acharya P, Chuang GY, Ofek G, Stewart-Jones GB, Stuckey J, Bailer RT, Joyce MG, Louder MK, Tumba N, Yang Y, Zhang B, Cohen MS, Haynes BF, Mascola JR, Morris L, Munro JB, Blanchard SC, Mothes W, Connors M, Kwong PD.

Nature. 2014 Oct 23;514(7523):455-61. doi: 10.1038/nature13808. Epub 2014 Oct 8.


Insight derived from molecular dynamics simulations into molecular motions, thermodynamics and kinetics of HIV-1 gp120.

Sang P, Yang LQ, Ji XL, Fu YX, Liu SQ.

PLoS One. 2014 Aug 8;9(8):e104714. doi: 10.1371/journal.pone.0104714. eCollection 2014.

Supplemental Content

Support Center